CVE:LXGLexagene Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Lexagene Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day RangeC$0.73MA: C$0.84▼C$0.9852-Week Range N/AVolume202,600 shsAverage Volume221,864 shsMarket CapitalizationC$83.27 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesSocial Media LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated pathogen detection platform in the life sciences and diagnostics industries. The company's platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. Its technology aims to transform the way organizations prevent and diagnose disease in various markets, such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and more. The company is headquartered in Beverly, Massachusetts.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Lexagene. Previous Next 2.5 Community Rank Outperform VotesLexagene has received 51 “outperform” votes. (Add your “outperform” vote.)Underperform VotesLexagene has received 52 “underperform” votes. (Add your “underperform” vote.)Community SentimentLexagene has received 50.49% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Lexagene and other stocks. Vote “Outperform” if you believe LXG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LXG will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldLexagene does not currently pay a dividend.Dividend GrowthLexagene does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Lexagene insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Lexagene is -10.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Lexagene is -10.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolCVE:LXG Previous Symbol CUSIPN/A CIKN/A Webwww.lexagene.com Phone800-215-1824Debt Debt-to-Equity Ratio49.71 Current Ratio6.57 Quick Ratio6.04Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow28.82 Book ValueC$0.04 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees20 Outstanding Shares85,688,800Market CapC$83.27 million Next Earnings DateN/A OptionableNot Optionable TSXV:LXG Rates by TradingView Receive LXG News and Ratings via Email Sign-up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter. Lexagene (CVE:LXG) Frequently Asked Questions Has Lexagene been receiving favorable news coverage? News coverage about LXG stock has trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Lexagene earned a news sentiment score of -1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Lexagene. Who are some of Lexagene's key competitors? Some companies that are related to Lexagene include Renalytix Ai (RENX), Volpara Health Tech (VHT), Legend Biotech (GTH), Akumin (AKU), MaxCyte (MXCT), Exagen (XGN), Yourgene Health (YGEN), Senseonics (SENS), Palatin Technologies (PTN), Oncimmune (ONC), Oncosil Medical (OSL), SQI Diagnostics (SQD), Genedrive (GDR), BARD1 Life Sciences (BD1) and Sernova (SVA). View all competitors. What other stocks do shareholders of Lexagene own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lexagene investors own include HIVE Blockchain Technologies (HIVE), EQT (EQT), Antibe Therapeutics (ATE), AzurRx BioPharma (AZRX), Bellicum Pharmaceuticals (BLCM), Inovio Pharmaceuticals (INO), Kirkland Lake Gold (KL), Know Labs (KNWN), Micron Technology (MU) and PING AN INS GRP/S (PNGAY). Who are Lexagene's key executives? Lexagene's management team includes the following people: Dr. John F. Regan, Founder, Chairman & CEOMr. Darrel M. Rebeck, Pres & DirectorMr. Jeffrey Mitchell, Chief Financial OfficerMr. Allan Fabbro, VP of Corp. Devel. What is Lexagene's stock symbol? Lexagene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LXG." How do I buy shares of Lexagene? Shares of LXG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. How big of a company is Lexagene? Lexagene has a market capitalization of C$0.00. Lexagene employs 20 workers across the globe. What is Lexagene's official website? The official website for Lexagene is www.lexagene.com. How can I contact Lexagene? The company can be reached via phone at 800-215-1824. This page was last updated on 7/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
